Berkshire Sterile client receives FDA approval on product indicated to reduce risk of hearing loss for childhood cancer patients
29 sept. 2022 11h00 HE
|
Berkshire Sterile Manufacturing
Lee, MA, Sept. 29, 2022 (GLOBE NEWSWIRE) -- On September 21st, 2022, Berkshire Sterile Manufacturing’s (BSM) client, Fennec Pharmaceuticals Inc., received FDA approval of their drug product, PEDMARK...